Skip to content
Close
SEARCH
CONTACT US
CONTACT US

OUR SERVICES

We take a personalized and integrated approach to help our clients position their pipelines and companies for success offering a full range of development and commercialization services.

VIEW ALL SERVICES
PHASES
DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
CLINICAL DEVELOPMENT
Advance through clinical
development and health
authority review with confidence.
ALL STAGES
Benefit from our expertise
across all phases
of drug development.
PRECLINICAL
Navigate the critical
preclinical testing phase
with expert guidance.
COMMERCIALIZATION
Successfully bring your
product to market with
our commercialization support.
ALL SERVICES
Access comprehensive
services for every stage
of product development.

ABOUT US

We are Halloran, a life science consulting firm, partnering to enrich your product development and business growth. We propel your organization further; positively impacting the health and wellbeing of patients around the world.

LEARN MORE ABOUT US
EXPERTISE WITH PERSONALITY
OUR FOUNDER
Discover the visionary
leader driving Halloran's
success and innovation.
STRATEGIC PARTNERS
Meet our trusted
strategic partners who
enhance our capabilities.
WHY HALLORAN?
Explore the unique reasons
why clients choose
Halloran for their needs.
OUR TEAM
Get to know the dedicated
professionals who make
up the Halloran team.
CAREERS
Join our dynamic team
and advance your
career with Halloran.
LEARN MORE
Find out more about
Halloran's comprehensive
services and expertise.
hcg-service-hero-1

Insights From Halloran

Lyn AgostinelliAug 21, 2024 12:45:00 PM2 min read

483 Issues to Sites – Indicators of Sponsor Oversight Effectiveness

A U.S. Food and Drug Administration (FDA) Form 483 is issued to a company’s management at ...
Start Reading
Shawn Roach, PhD, RACAug 8, 2024 1:45:00 PM1 min read

Clinical Development Considerations for Small Molecules and Recombinant Proteins

Navigating the complexities of Chemistry, Manufacturing, and Controls (CMC) within the ...
Start Reading
Hema BalasubramanianAug 2, 2024 11:30:00 AM7 min read

How, Why, and When to Apply for an Orphan Drug Application

This article is written by Hema Balasubramanian and Mamta Puri-Lechner. In the rapidly ...
Start Reading
Katie W McCarthyJul 10, 2024 4:33:00 PM1 min read

Key Strategies for Development Stage Biotechs: Developing an Organization and the Talent Within

Watch “Key Strategies for Development Stage Biotechs: Developing an Organization and the ...
Start Reading
April PurcellJul 10, 2024 3:57:00 PM5 min read

Catching Up with Consulting — DIA 2024 Insights

This article is based on opinions and perceptions from the DIA 2024 Global Annual ...
Start Reading
Gail WinslowJul 3, 2024 4:00:00 PM4 min read

Generative AI-Driven Clinical Trials: Are We There Yet?

This article is based on the session titled, “Generative AI-Driven Clinical Trials: Myth ...
Start Reading
Halloran Consulting GroupJul 3, 2024 9:00:00 AM3 min read

Clinical Trials in 2024 - Are We Making the Grade?

Clinical Trials in 2024 - Are We Making the Grade? This article is based on the session ...
Start Reading
Halloran Consulting GroupJul 3, 2024 8:30:00 AM3 min read

The Upside of Artificial Intelligence on Medical Writing

The Upside of Artificial Intelligence on Medical Writing This article is based on the ...
Start Reading
Halloran Consulting GroupJul 2, 2024 9:49:00 AM4 min read

Building Your Leadership Superpowers

Building Your Leadership Superpowers This article is based on the session titled, ...
Start Reading
Gail WinslowJul 2, 2024 8:57:00 AM5 min read

RWD and RWE for Regulatory and Health Technology Assessments

This article is based on the session “Real-World Evidence (RWE) for Regulatory and Health ...
Start Reading
Load more posts